Page 9 - Contract Development News Today

Teva and mAbxience enter into a strategic global partnership for in-licensing of an oncology biosimilar candidate Agreement signals a major step in mAbxiences global expansion strategy and...

CRANBURY, N.J. & DUBLIN, April 03, 2024--Experic appoints Philip Dunne as Director of EU Operations, bringing 25+ years of clinical trial supply expertise to their new Dublin facility.

Asit C Mehta is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 171 in its research report dated April 01 2024.

The biopharmaceutical landscape is flourishing, with antibody-based therapeutics at the forefront of innovation. Click to read more...

MADISON, Wis.--(BUSINESS WIRE)--Apr 2, 2024--

Chicago, March 29, 2024 (GLOBE NEWSWIRE) -- Pharmaceutical Membrane Filtration market in terms of revenue was estimated to be worth $10.6 billion in 2024...

First-of-its-kind park in York Region expected to bring in over 1,700 jobs

 Press Release     Paris – March 28, 2024 – EUROAPI today announces that its 2023 Universal Registration Document will be filed with the French Financial Markets Authority on April 5, 2024. ...

/PRNewswire/ -- Kytopen Corp., a leader in the development of manufacturing platforms and workflows for advanced therapeutic medicines, announces the launch of...

Getinge and CellRev launch platform with potential to transform allogeneic cell therapy manufacturing Press release | 3/25/2024 Getinge has partnered with...